Another phase 2 study investigating the effect of bezafibrate on bipolar depression (NCT02481245) depended on the concept that mitochondrial dysregulation is attributable to bipolar depression, which could be ameliorated by PPAR pan agonists, such as bezafibrate. The gene discussed is PPARA; the disease is bipolar disorder.